Irrespective of the SP, the new announcement will further derisk as Dr T has said.
The probability to have a successful Phase II for Pillar II from this announcement has increased. With preclinicals demonstrating better efficacy as well as making it more likely for clinical trials to be set up as there are more types of breast cancer that we can use for salvage therapy in our trials.
Coupled with safety data, this is great and has made my previous post age quite poorly.
Understanding RAC, page-27
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.77 |
Change
0.015(0.86%) |
Mkt cap ! $303.1M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.77 | $91.78K | 51.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 31147 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 8318 | 1 |
View Market Depth
| Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |